Amyris Adds $20 Million

Amyris Biotechnologies Inc., an Emeryville, Calif.-based synthetic biology company that developers renewable hydrocarbon biofuels, has expanded its Series B round from $70 million to around $90 million, according to a regulatory filing. So far, it has called down just over $50 million of that amount. No new investors are listed. DAG Ventures was the original round lead, with Khosla Ventures, Kleiner Perkins Caufield & Byers and TPG Ventures also participating.